Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry - Summary - MDSpire

Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry

  • By

  • Mustafa Yildirim

  • Christian Salbach

  • Johannes Dürr

  • Matthias Mueller-Hennessen

  • Hugo A. Katus

  • Norbert Frey

  • Evangelos Giannitsis

  • April 15, 2026

  • 0 min

Share

Objective:

To assess the prevalence of type 1 and type 2 myocardial infarction (MI) among patients with atrial fibrillation (AF) and NSTEMI, utilizing coronary angiography for subtype assignment, particularly focusing on the implications of angiographic findings.

Key Findings:
  • A significant proportion of patients with NSTEMI and AF were diagnosed with type 2 MI based on hs-cTnT levels without systematic angiographic evaluation, indicating a potential misclassification.
  • The study revealed a higher prevalence of type 1 MI than previously reported in studies with low rates of coronary angiography, suggesting that previous estimates may underestimate the true incidence.
  • Coronary angiography provided critical insights into the underlying coronary anatomy and mechanisms of MI in AF patients, highlighting the need for systematic evaluation.
Interpretation:

The findings suggest that type 1 MI may be under-recognized in AF patients when relying solely on clinical judgment and troponin dynamics, emphasizing the importance of angiographic evaluation for accurate diagnosis and treatment.

Limitations:
  • The study is retrospective and may be subject to selection bias despite efforts to minimize it.
  • Findings are based on a single-center registry, which may limit generalizability and applicability to broader populations.
Conclusion:

The study underscores the necessity of systematic coronary angiography in accurately diagnosing MI subtypes in AF patients, potentially altering treatment approaches.

Original Source(s)

Related Content